Biokinetics of indium-111-bleomycin complex in head and neck cancer - Implementations for radiochemotherapy

Cancer Detection and Prevention

Volumn 21, Issue 1, 1997, Pages 83-90

  Kairemo, K J A ^a   Ramsay, H A ^a   Paavonen, T K ^a   Jaaskela Saari, H A ^a   Tagesson, M ^a   Ljunggren, K ^a   Strand, S E ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

Adjuvant chemotherapy; Bleomycin; Head and neck neoplasms; Indium radioisotopes; Radiation therapy; Radionuclide imaging

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; BLEOMYCIN INDIUM; DRUG DERIVATIVE; INDIUM; INDIUM-BLEOMYCIN; ORGANOMETALLIC COMPOUND;

ADULT; AGED; ARTICLE; CELL DIVISION; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HALF LIFE TIME; HEAD AND NECK TUMOR; HUMAN; KIDNEY; MALE; METABOLISM; MIDDLE AGED; MONTE CARLO METHOD; MULTIMODALITY CANCER THERAPY; RADIATION EXPOSURE; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BLEOMYCIN; CARCINOMA, SQUAMOUS CELL; CELL DIVISION; COMBINED MODALITY THERAPY; FEMALE; HALF-LIFE; HEAD AND NECK NEOPLASMS; HUMANS; INDIUM RADIOISOTOPES; KIDNEY; MALE; MIDDLE AGED; MONTE CARLO METHOD; ORGANOMETALLIC COMPOUNDS;

EID: 0030805018     PISSN: 0361090X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)